Eupressyl

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	34.3%
Hypertension	20.3%
Drug Use For Unknown Indication	15.2%
Haemolytic Uraemic Syndrome	5.4%
Arthralgia	4.1%
Anxiety	3.2%
Diabetes Mellitus	2.8%
Atrial Fibrillation	2.1%
Thrombosis Prophylaxis	1.7%
Pain	1.5%
Anaemia	1.4%
Rheumatoid Arthritis	1.4%
Osteoarthritis	1.2%
Epilepsy	1.1%
Pulmonary Embolism	0.9%
Embolism	0.7%
Hypercholesterolaemia	0.7%
Aortic Dissection	0.6%
Diarrhoea	0.6%
Ill-defined Disorder	0.6%

Drug Rash With Eosinophilia And Systemic Symptoms	7.1%
Thrombocytopenia	7.1%
Cytolytic Hepatitis	6.2%
Renal Failure	6.2%
Tubulointerstitial Nephritis	6.2%
Vascular Purpura	6.2%
Cardio-respiratory Arrest	5.3%
Fall	5.3%
Hyponatraemia	5.3%
Renal Failure Acute	5.3%
Anaemia	4.4%
Malaise	4.4%
Nausea	4.4%
Orthostatic Hypotension	4.4%
Pulmonary Oedema	4.4%
Leukocytoclastic Vasculitis	3.5%
Nephropathy	3.5%
Pruritus	3.5%
Sudden Death	3.5%
Ventricular Arrhythmia	3.5%

Concomitant

Hypertension	26.4%
Product Used For Unknown Indication	24.9%
Drug Use For Unknown Indication	14.8%
Hiv Infection	5.6%
Renal Transplant	4.0%
Hepatitis C	3.1%
Type 2 Diabetes Mellitus	2.6%
Diabetes Mellitus	2.2%
Coronary Artery Disease	1.7%
Atrial Fibrillation	1.5%
Hypothyroidism	1.5%
Prophylaxis	1.5%
Anxiety	1.3%
Prophylaxis Against Transplant Rejection	1.3%
Bronchial Disorder	1.3%
Immunosuppression	1.3%
Anaemia	1.2%
Depression	1.2%
Insomnia	1.2%
Lung Disorder	1.2%

Renal Failure Acute	13.5%
Neutropenia	7.3%
Renal Failure	6.7%
Vomiting	6.7%
Thrombocytopenia	6.2%
Toxic Skin Eruption	6.2%
Leukopenia	5.1%
Anaemia	4.5%
Cholestasis	4.5%
Hyponatraemia	4.5%
Renal Tubular Disorder	4.5%
Weight Increased	4.5%
Rhabdomyolysis	3.9%
Cytolytic Hepatitis	3.4%
Rash Maculo-papular	3.4%
Thrombotic Microangiopathy	3.4%
Weight Decreased	3.4%
Convulsion	2.8%
International Normalised Ratio Increased	2.8%
Lymphoedema	2.8%